THE VACCINE MAKER MODERNA decided this past week to tell the world about bad news it had received from the federal government ...
Márcio Temtem, Hovione, discusses how to tackle pharma complexity via regional growth in the US, Ireland, and Portugal, using digital tools to accelerate development.
ADCs combine antibodies with drug payloads for targeted therapy, but complex manufacturing requires monitoring CQAs across multiple entities.
A year of significant policy change at the FDA brought momentum and scrutiny into the new year. As 2026 gets underway, biopharma companies are responding to sweeping vaccine changes while concerns ...
By Ahmed Aboulenein WASHINGTON, Feb 1 (Reuters) - The U.S. Food and Drug Administration on Sunday began accepting requests to participate in its PreCheck pilot program, designed to boost domestic drug ...
Cash Position -- $131.7 million in cash and cash equivalents as of December 31, 2025, with no debt reported. Operating ...
Marcio Temtem, vice president, Strategic Business Management, Hovione, addresses molecule complexity, speed, and ...
BioRestorative completed a Type B meeting with the U.S. Food and Drug Administration ('FDA”) regarding a potential accelerated Biologics License Application ('BLA”) approval pathway for the Fast-Track ...
SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results